Can the plan be signed electronically?

Yes. Under the federal ESIGN Act (15 U.S.C. ch. 96) and UETA-adopting state laws, electronic signatures are valid for most contracts and internal plans. Exceptions include wills and certain court filings; confirm with legal counsel.

Are notarization and witnesses required?

Generally no for internal control plans; notarization and witness requirements apply to specific legal instruments such as deeds, wills, and powers of attorney. If institutional policy or regulation demands notarization, follow local notary or RON procedures and document retention rules.

Which records to retain and for how long

Retain monitoring data, lab reports, corrective action records, training logs, and versioned plan copies. Federal baselines include IRS three-year rules and HIPAA six-year retention for health records; industry-specific standards may require longer retention periods.

Can I use eSign platforms to collect signatures?

Yes. Choose a platform that records an audit trail, supports required authentication, and complies with ESIGN/UETA. For protected health information or FDA-regulated records, ensure HIPAA BAA or 21 CFR Part 11 capabilities are available.

How to handle deviations and recalls

Document deviation investigations, quarantine affected batches, notify stakeholders, and execute corrective and preventive actions. Preserve pre- and post-corrective test results for root-cause analysis and regulatory review; update the plan to prevent recurrence.

Who should sign the plan?

Authorized signers typically include the quality manager, biosafety officer, laboratory director, and senior management representative. Document authority levels in the responsibilities section and ensure signatures match personnel listed in the plan to maintain administrative control.

Electronic Signature
Templates
Miscellaneous
Microbiological Control Plan

Microbiological Control Plan

This template is fully customizable. Edit the text, fill out the fields, and send it for signature. Give it a try!

MICROBIOLOGICAL CONTROL PLAN

This Microbiological Control Plan (the Plan) is entered into by and between Company Name: and Service Provider Name: .

WHEREAS

WHEREAS, Company requires a documented program to manage microbiological hazards, ensure product safety and compliance with applicable quality standards; and

WHEREAS, Service Provider has experience in microbiological monitoring, sampling, testing and corrective action implementation and agrees to perform services under the terms of this Plan; and

WHEREAS, the parties intend that this Plan define scope, responsibilities, sampling and control measures necessary to manage microbiological risk within Company facilities or processes.

DEFINITIONS

For purposes of this Plan, "Action Level" means the microbiological threshold requiring documented corrective action; "Sample Point" means specified location where samples are collected; "Holding Time" means maximum time between sample collection and analysis.

SCOPE OF WORK

Scope Description

ROLES AND RESPONSIBILITIES

Company Representative Service Provider Representative

SAMPLING PLAN

Sample Frequency: Number of Sample Points:

Sample Point Locations and Rationale Analytical Methods / Laboratory

MONITORING AND ACCEPTANCE CRITERIA

Target Organisms / Parameters Action Levels and Acceptance Criteria

CORRECTIVE ACTION

Corrective Action Procedure

Escalation Steps:

RECORDKEEPING

All microbiological records, including raw data, chain-of-custody, corrective action reports, and verification records, will be retained for a minimum retention period of .

Location of Records

TRAINING

Training Responsible

Training Frequency:

REVIEW AND AUDIT

Management Review Frequency:

Internal Audit Scope

PAYMENT TERMS

Compensation for services rendered under this Plan shall be:

Total Amount Payment Schedule

Late Payment Fee (applied to overdue invoices):

TERM AND TERMINATION

Effective Date: Month Day Year .

Termination Date: Month Day Year .

Either party may terminate this Plan for convenience upon written notice to the other party delivered at least days prior to termination. Termination for cause may be immediate if the non‑performing party fails to remediate a critical microbiological hazard within a time specified by the other party.

CONFIDENTIALITY

Each party shall maintain in confidence all non-public information disclosed under this Plan, including but not limited to sampling results, laboratory data, corrective action reports and process control parameters. Confidential information shall not be used except to perform obligations under this Plan and shall not be disclosed to third parties without prior written consent, except where disclosure is required by law. The confidentiality obligations shall survive termination of this Plan for a period of three (3) years.

GOVERNING LAW

This Plan shall be governed by and construed in accordance with the laws of the State of without regard to its conflict of laws principles.

LIMITATION OF LIABILITY

Except for willful misconduct or gross negligence, neither party shall be liable to the other for incidental, indirect, special or consequential damages arising out of or in connection with this Plan. The aggregate liability of either party for claims arising under or related to this Plan shall not exceed the total fees paid to Service Provider under this Plan in the twelve (12) months preceding the event giving rise to the claim.

ENTIRE AGREEMENT

This Plan, including any attachments and exhibits incorporated by written reference, constitutes the entire agreement between the parties with respect to the subject matter hereof and supersedes all prior or contemporaneous agreements, representations and understandings, whether written or oral. Any amendment to this Plan must be in writing and signed by authorized representatives of both parties.

ATTACHMENTS

Attachment List (sampling maps, laboratory methods, forms)

By signing below, the parties acknowledge that they have read, understand and agree to be bound by the terms of this Microbiological Control Plan.

Company Name:

By:

Date:

Service Provider:

By:

Date:

What the Microbiological Control Plan Is

The Microbiological Control Plan is a documented, systematic program that defines procedures, personnel responsibilities, monitoring, and corrective actions to control microbiological hazards in laboratory, clinical, pharmaceutical, and food production environments. It typically includes sampling strategies, acceptance criteria, environmental monitoring schedules, cleaning and disinfecting protocols, training requirements, and documentation standards needed to demonstrate compliance with applicable regulations and internal quality systems. The plan helps organizations reduce contamination risk, verify process controls, and provide traceable records for audits, inspections, and product release decisions.

Why a Formal Plan Matters

A Microbiological Control Plan clarifies responsibilities, documents controls, and supports regulatory compliance. It reduces contamination incidents, standardizes monitoring, and provides audit-ready records for inspections, internal reviews, and product release decisions across clinical, manufacturing, and research settings.

Who Typically Prepares and Uses This Plan

Typical users include quality managers, biosafety officers, laboratory supervisors, production managers, and regulatory compliance teams.

Quality managers design and approve control strategies, monitoring plans, and corrective actions.
Biosafety officers ensure containment, PPE protocols, and alignment with institutional biosafety requirements.
Laboratory supervisors execute environmental monitoring, sample collection, and staff training on SOPs.

Use the plan when establishing monitoring programs, preparing for audits, or documenting corrective actions after contamination events.

Core Sections Every Plan Should Include

Core sections define scope, monitoring methods, corrective actions, roles and responsibilities, recordkeeping practices, and review schedules to maintain microbiological control.

Scope

Describe facilities, processes, products, and operational limits covered by the plan; specify exclusion criteria and interfaces with other quality or safety programs to avoid ambiguity during audits and inspections.

Monitoring

Define environmental sampling locations, frequencies, sample types, methods, and acceptance criteria; include calibrated equipment lists and chain-of-custody procedures to ensure data integrity and traceability for investigations.

Corrective Actions

Establish escalation matrices, investigation steps, root-cause analysis methods, immediate containment measures, and verification testing to confirm remediation before resuming routine operations or releasing affected product lots.

Responsibilities

Assign clear roles for sample collection, lab analysis, data review, and corrective action ownership; include contact lists and authorization levels for deviation approvals and emergency decisions.

Records

Specify retention, format, and review frequency for raw data, laboratory reports, logbooks, and training records; require audit trails and timestamped entries compatible with regulatory and accreditation requirements.

Review

Schedule periodic management reviews and trend analyses, define trigger thresholds for corrective program updates, and document version control to ensure the plan remains current with process or regulatory changes.

Essential Information to Record

Plan Owner: Name and contact information

Effective Date: Enter as MM/DD/YYYY format

Scope: Processes, areas, products included

Monitoring Plan: Sampling sites, frequency, methods

Acceptance Criteria: Limits for pass/fail and actions

Retention: Record retention period specified

Step-by-Step: Create and Implement the Plan

Follow these steps to complete and implement a Microbiological Control Plan, from drafting to approval and routine monitoring.

01

Draft Plan: Document scope, responsibilities, monitoring, and corrective actions.
02

Define Methods: Specify sampling methods, equipment, and laboratory procedures.
03

Review & Approve: Obtain sign-off from quality and biosafety authorities.
04

Implement: Train staff, start monitoring, and record results.

Configure an Online Template for eSubmission

Configure the online Microbiological Control Plan template to capture required fields, enforce formats, and route approvals automatically for efficient eSubmission.

Field	Configuration
Template Name	Use standard file name for version control
Required Fields	Enable full name, date, scope, and signatures
Validation Rules	Set MM/DD/YYYY, zip code, and numeric limits
Approval Flow	Route to biosafety, QA, then management signer

Typical Routing from Draft to Archive

Typical submission and review path for the Microbiological Control Plan, from drafting through approval and archival in quality systems.

Prepare Document: Draft plan and attach SOPs and supporting data.
Assign Reviewers: Add biosafety and QA reviewers with deadlines.
Sign & Approve: Collect electronic signatures and record timestamps.
Archive: Store signed PDF and audit trail in records system.

Technical Requirements for eSubmission and Records

For eSubmission, ensure the platform supports secure PDFs, audit trails, role-based access, and complies with applicable regulations like HIPAA and 21 CFR Part 11 where required.

Document Formats: PDF, DOCX and editable templates
Integrations: Connectors: NetSuite, Salesforce, Box, Google Workspace
Security: AES-256 at rest, TLS 1.2/1.3 transit

Key Timelines and Review Intervals

Key timelines include plan approval, initial environmental monitoring, periodic review, corrective action deadlines, and scheduled management reviews to ensure ongoing control.

Plan approval and authorization deadline:

Approve prior to production start or within 30 days of adoption.

Initial monitoring start and reporting deadline:

Begin baseline sampling immediately after facility readiness; report within 14 days.

Periodic plan review and update interval:

Conduct formal review at least annually; more frequently for deviations.

Corrective action response and verification timeframe:

Containment within 24 hours; root cause and verification within 7 days.

Management review and trend analysis schedule:

Quarterly reviews recommended; escalate persistent trends to senior management.

Milestones from Draft to Continuous Control

Sequential milestones guide plan lifecycle from initial drafting to review, corrective actions, validation, and final archival to create a continuous control loop.

01

Draft & Scope

Define scope, roles, and baseline monitoring points.

02

Validation Testing

Execute verification studies and compare against acceptance criteria.

03

Approval

Formal sign-off by QA, biosafety, and management stakeholders.

04

Ongoing Monitoring

Continuous sampling, trend review, and periodic plan updates.

Common Preparation and Implementation Pitfalls

Inadequate scope definition leaving critical areas unmonitored, causing blind spots that delay detection of contamination events and complicate corrective investigations during regulatory inspections.
Vague acceptance criteria or inconsistent limits across labs, resulting in unclear pass/fail decisions and excessive retesting that undermines trend analysis.
Poor documentation practices such as missing timestamps, incomplete chain-of-custody, or unsigned records that increase audit risk and may invalidate results.
Insufficient training and unclear responsibilities for sample collection or equipment calibration leading to variability in data and false positive or negative signals.

Regulatory and Operational Risks of an Incomplete Plan

Regulatory Citations: Inspection findings and warning letters

Product Recall: Lot holds or market removal

Operational Downtime: Production stoppage, lost revenue

Safety Incidents: Worker or patient exposure risk

Legal Liability: Civil claims and damages

Accreditation Risk: Loss of certification status

eSignature Plan Comparison for Completing the Plan

Comparison of common eSignature plan criteria relevant to completing and signing Microbiological Control Plans; signNow listed first per vendor data.

	signNow	DocuSign	Adobe Sign	PandaDoc	HelloSign
Starting Price	$8/user/mo	$15/user/mo	$14/user/mo	$19/user/mo	$15/user/mo
Free Trial	7-day free trial	Varies by plan and region	Varies by plan and region	Varies by plan and region	Varies by plan and region
Bulk Send	Yes (Business Premium)	Yes	Yes	Yes	No
Audit Trail	Yes	Yes	Yes	Yes	Yes
HIPAA Compliant	Yes	Yes	Yes	No	No

Frequently Asked Questions and Troubleshooting

Answers to common questions on preparing, signing, and managing a Microbiological Control Plan, including digital submission, compliance, and recordkeeping concerns.

Need help? Contact support

Can the plan be signed electronically?
Yes. Under the federal ESIGN Act (15 U.S.C. ch. 96) and UETA-adopting state laws, electronic signatures are valid for most contracts and internal plans. Exceptions include wills and certain court filings; confirm with legal counsel.
Are notarization and witnesses required?
Generally no for internal control plans; notarization and witness requirements apply to specific legal instruments such as deeds, wills, and powers of attorney. If institutional policy or regulation demands notarization, follow local notary or RON procedures and document retention rules.
Which records to retain and for how long
Retain monitoring data, lab reports, corrective action records, training logs, and versioned plan copies. Federal baselines include IRS three-year rules and HIPAA six-year retention for health records; industry-specific standards may require longer retention periods.
Can I use eSign platforms to collect signatures?
Yes. Choose a platform that records an audit trail, supports required authentication, and complies with ESIGN/UETA. For protected health information or FDA-regulated records, ensure HIPAA BAA or 21 CFR Part 11 capabilities are available.
How to handle deviations and recalls
Document deviation investigations, quarantine affected batches, notify stakeholders, and execute corrective and preventive actions. Preserve pre- and post-corrective test results for root-cause analysis and regulatory review; update the plan to prevent recurrence.
Who should sign the plan?
Authorized signers typically include the quality manager, biosafety officer, laboratory director, and senior management representative. Document authority levels in the responsibilities section and ensure signatures match personnel listed in the plan to maintain administrative control.

be ready to get more

Join over 28 million airSlate SignNow users

Sign Now